FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953523721> ?p ?o ?g. }

• W2953523721 endingPage "2276" @default.
• W2953523721 startingPage "2276" @default.
• W2953523721 abstract "Abstract Purpose The field of circulating cell free DNA (cfDNA) testing is quickly developing. Multiple platforms to detect hotspot mutations in ctDNA are available, including Bio-Rad droplet digital PCR (ddPCR), BioCartis Idylla, Roche COBAS z480 and Sysmex BEAMing. These platforms vary in the amount of plasma required, the method of ctDNA isolation, the number of hotspots analyzed, and the costs per sample. These factors can impact the applicability of a specific platform in the analysis of ctDNA. In this study we compared these platforms in terms of sensitivity and total costs per sample. Methods The platform comparison was performed as follows: 1. Plasma from six metastatic colorectal cancer (mCRC) patients with known tissue KRAS mutation status was analyzed according to the manufacturers’ protocols. 2. Sensitivity was tested using six constructed reference samples with seven KRAS hotspot mutations at various total input (10ng, 50ng) and mutant allele frequencies (0%, 0.04%, 0.50%); each in four replicates. 3. Twelve mCRC patients were analyzed using equal amounts of ctDNA for each platform. 4. Total costs per sample were evaluated, including costs for consumables, technician hands-on time, equipment and maintenance. Results 1. In six mCRC samples BEAMing (3ml plasma) detected 5/6 mutations, ddPCR and Idylla (both 1ml plasma) 4/6 mutations and COBAS z480 (2ml plasma) 3/6 mutations. 2. In constructed reference samples ddPCR (65%) and BEAMing (46%) yielded the highest sensitivity. With 10ng input BEAMing and COBAS z480 produced “Too little DNA” errors in 60% and 100% of cases, respectively. 3. In twelve mCRC samples, eight had more than 10ng ctDNA and four had less. All platforms were fully concordant for samples with more than 10ng input. Detection rate across twelve samples: Idylla detected 7/11 detectable mutations, COBAS z480 and BEAMing both detected 5/11, ddPCR detected 4/10. 4. BEAMing has the highest cost per sample (€486-€821) whereas ddPCR has the lowest cost per sample (€39-€298). Conclusions A direct comparison of ctDNA mutation detection platforms is complex and should take into account the differences in input and output specifications of the platforms. Factors such as complexity of analysis (Idylla is a low complexity platform, whereas BEAMing requires more specialized training), total costs (varying from ddPCR to BEAMing), sensitivity (ddPCR and BEAMing yielded the highest sensitivity) and the number of mutations evaluated vary greatly between the platforms. All these factors influence ctDNA analysis and will have to be considered when choosing a specific platform for a specific (clinical) question, or when comparing results between studies. Our data provide insight in the comparative performance of four commercial ctDNA analysis platforms, allowing future users to make an informed decision regarding a platform. Acknowledgement Powered by Health~Holland, Top Sector Life Sciences & Health, grant LSHM16047-H005. Citation Format: Daan C. Vessies, Marjolein J. Greuter, Karlijn L. van Rooijen, Theodora C. Linders, Mirthe Lanfermeijer, Kalpana L. Ramkisoensing, Flore E. Grijseels, Boris van Doorn, Gerrit A. Meijer, Miriam Koopman, Veerle M. Coupé, Geraldine R. Vink, Remond J. Fijneman, Daan van den Broek. Performance and cost comparison of circulating tumor DNA detection platforms [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2276." @default.
• W2953523721 created "2019-07-12" @default.
• W2953523721 creator A5004996171 @default.
• W2953523721 creator A5035091897 @default.
• W2953523721 creator A5037614106 @default.
• W2953523721 creator A5040466517 @default.
• W2953523721 creator A5049451329 @default.
• W2953523721 creator A5050300249 @default.
• W2953523721 creator A5053630554 @default.
• W2953523721 creator A5057744516 @default.
• W2953523721 creator A5061172196 @default.
• W2953523721 creator A5067695469 @default.
• W2953523721 creator A5070586913 @default.
• W2953523721 creator A5077029853 @default.
• W2953523721 creator A5078199964 @default.
• W2953523721 creator A5078470750 @default.
• W2953523721 date "2019-07-01" @default.
• W2953523721 modified "2023-10-01" @default.
• W2953523721 title "Abstract 2276: Performance and cost comparison of circulating tumor DNA detection platforms" @default.
• W2953523721 doi "https://doi.org/10.1158/1538-7445.am2019-2276" @default.
• W2953523721 hasPublicationYear "2019" @default.
• W2953523721 type Work @default.
• W2953523721 sameAs 2953523721 @default.
• W2953523721 citedByCount "1" @default.
• W2953523721 countsByYear W29535237212021 @default.
• W2953523721 crossrefType "journal-article" @default.
• W2953523721 hasAuthorship W2953523721A5004996171 @default.
• W2953523721 hasAuthorship W2953523721A5035091897 @default.
• W2953523721 hasAuthorship W2953523721A5037614106 @default.
• W2953523721 hasAuthorship W2953523721A5040466517 @default.
• W2953523721 hasAuthorship W2953523721A5049451329 @default.
• W2953523721 hasAuthorship W2953523721A5050300249 @default.
• W2953523721 hasAuthorship W2953523721A5053630554 @default.
• W2953523721 hasAuthorship W2953523721A5057744516 @default.
• W2953523721 hasAuthorship W2953523721A5061172196 @default.
• W2953523721 hasAuthorship W2953523721A5067695469 @default.
• W2953523721 hasAuthorship W2953523721A5070586913 @default.
• W2953523721 hasAuthorship W2953523721A5077029853 @default.
• W2953523721 hasAuthorship W2953523721A5078199964 @default.
• W2953523721 hasAuthorship W2953523721A5078470750 @default.
• W2953523721 hasConcept C104317684 @default.
• W2953523721 hasConcept C121608353 @default.
• W2953523721 hasConcept C126322002 @default.
• W2953523721 hasConcept C143998085 @default.
• W2953523721 hasConcept C2781187634 @default.
• W2953523721 hasConcept C2781335228 @default.
• W2953523721 hasConcept C48126324 @default.
• W2953523721 hasConcept C49105822 @default.
• W2953523721 hasConcept C526805850 @default.
• W2953523721 hasConcept C54355233 @default.
• W2953523721 hasConcept C71924100 @default.
• W2953523721 hasConcept C86803240 @default.
• W2953523721 hasConceptScore W2953523721C104317684 @default.
• W2953523721 hasConceptScore W2953523721C121608353 @default.
• W2953523721 hasConceptScore W2953523721C126322002 @default.
• W2953523721 hasConceptScore W2953523721C143998085 @default.
• W2953523721 hasConceptScore W2953523721C2781187634 @default.
• W2953523721 hasConceptScore W2953523721C2781335228 @default.
• W2953523721 hasConceptScore W2953523721C48126324 @default.
• W2953523721 hasConceptScore W2953523721C49105822 @default.
• W2953523721 hasConceptScore W2953523721C526805850 @default.
• W2953523721 hasConceptScore W2953523721C54355233 @default.
• W2953523721 hasConceptScore W2953523721C71924100 @default.
• W2953523721 hasConceptScore W2953523721C86803240 @default.
• W2953523721 hasIssue "13_Supplement" @default.
• W2953523721 hasLocation W29535237211 @default.
• W2953523721 hasOpenAccess W2953523721 @default.
• W2953523721 hasPrimaryLocation W29535237211 @default.
• W2953523721 hasRelatedWork W1996349887 @default.
• W2953523721 hasRelatedWork W2313360580 @default.
• W2953523721 hasRelatedWork W2323306940 @default.
• W2953523721 hasRelatedWork W2413380883 @default.
• W2953523721 hasRelatedWork W2972884351 @default.
• W2953523721 hasRelatedWork W2987507797 @default.
• W2953523721 hasRelatedWork W2999902763 @default.
• W2953523721 hasRelatedWork W3021444318 @default.
• W2953523721 hasRelatedWork W3026015583 @default.
• W2953523721 hasRelatedWork W4213442952 @default.
• W2953523721 hasVolume "79" @default.
• W2953523721 isParatext "false" @default.
• W2953523721 isRetracted "false" @default.
• W2953523721 magId "2953523721" @default.
• W2953523721 workType "article" @default.